Interaction of Treatment and Biomarker in Advanced Non-small Cell Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|12|1|51-58

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.12, Iss.1, 2017-01, pp. : 51-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy in Elderly Patients with Advanced Lung Cancer Part II: Treatment of Non-Small Cell Lung Cancer (NSCLC)

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 583-588

Karger

Access to resources Recommend Favorite

Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 350-358

Karger

Access to resources Recommend Favorite

Erlotinib after Failure of Gefitinib Treatment of More Than 6 Months in Advanced Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 1-2, 2012-01 ,pp. : 8-9

Karger

Access to resources Recommend Favorite

Old Wine in New Pipes? Treatment of Advanced Non-Small Cell Lung Cancer with Trofosfamide

By  

Oncology Research and Treatment, Vol. 36, Iss. 7-8, 2013-07 ,pp. : 409-413

Karger

Access to resources Recommend Favorite

Targeted therapy in lung cancer

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 3, 2015-04 ,pp. : 370-378

John Wiley & Sons Inc

Access to resources Recommend Favorite